NCT07164859View on ClinicalTrials.gov

Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,700

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2029

Study Completion Date

October 31, 2029

Conditions
Coronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI)Antiplatelet TherapyElderly (People Aged 65 or More)
Interventions
DRUG

short dual antiplatelet therapy (DAPT) duration

patients will receive DAPT for 7 days (after randomization) followed by P2Y12 inhibitor alone

DRUG

Standard DAPT duration

patients will receive DAPT for at least 3 months after randomization or longer and followed by single antiplatelet therapy

Trial Locations (1)

14000

Caen University Hospital, Caen

All Listed Sponsors
lead

Vincent ROULE

OTHER